Capital Research Global Investors Merck & Co., Inc. Transaction History

Capital Research Global Investors

  • $443 Billion
  • Q2 2024

A detailed history of Capital Research Global Investors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Capital Research Global Investors holds 2,041,274 shares of MRK stock, worth $232 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,041,274
Previous 2,041,458 0.01%
Holding current value
$232 Million
Previous $269 Million 6.19%
% of portfolio
0.06%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$123.8 - $132.96 $22,779 - $24,464
-184 Reduced 0.01%
2,041,274 $253 Million
Q1 2024

May 14, 2024
BUY
$113.24 - $131.95 $184,920 - $215,474
1,633 Added 0.08%
2,041,458 $269 Million
Q4 2023

Feb 13, 2024
SELL
$100.18 - $109.02 $45,982 - $50,040
-459 Reduced 0.02%
2,039,825 $222 Million
Q3 2023

Nov 13, 2023
BUY
$102.95 - $114.33 $117,465 - $130,450
1,141 Added 0.06%
2,040,284 $210 Million
Q2 2023

Aug 11, 2023
BUY
$108.61 - $118.38 $42,466 - $46,286
391 Added 0.02%
2,039,143 $235 Million
Q1 2023

May 15, 2023
BUY
$102.94 - $114.86 $88,322 - $98,549
858 Added 0.04%
2,038,752 $217 Million
Q4 2022

Feb 14, 2023
BUY
$87.44 - $112.11 $85,428 - $109,531
977 Added 0.05%
2,037,894 $226 Million
Q3 2022

Nov 14, 2022
BUY
$84.53 - $94.96 $4,818 - $5,412
57 Added 0.0%
2,036,917 $175 Million
Q2 2022

Aug 15, 2022
SELL
$83.49 - $94.64 $9,684 - $10,978
-116 Reduced 0.01%
2,036,860 $186 Million
Q1 2022

May 16, 2022
BUY
$73.51 - $82.4 $75,641 - $84,789
1,029 Added 0.05%
2,036,976 $167 Million
Q4 2021

Feb 14, 2022
SELL
$72.28 - $90.54 $19.9 Million - $24.9 Million
-275,548 Reduced 11.92%
2,035,947 $156 Million
Q3 2021

Nov 15, 2021
BUY
$71.68 - $78.83 $88,596 - $97,433
1,236 Added 0.05%
2,311,495 $174 Million
Q2 2021

Aug 16, 2021
SELL
$70.31 - $77.77 $214 Million - $237 Million
-3,043,150 Reduced 56.85%
2,310,259 $180 Million
Q1 2021

May 14, 2021
SELL
$68.86 - $81.11 $16.3 Million - $19.2 Million
-236,836 Reduced 4.24%
5,353,409 $413 Million
Q4 2020

Feb 12, 2021
BUY
$71.77 - $79.65 $179,496 - $199,204
2,501 Added 0.04%
5,590,245 $457 Million
Q3 2020

Nov 13, 2020
SELL
$73.18 - $82.95 $81,156 - $91,991
-1,109 Reduced 0.02%
5,587,744 $464 Million
Q2 2020

Aug 14, 2020
BUY
$70.42 - $80.13 $475,335 - $540,877
6,750 Added 0.12%
5,588,853 $432 Million
Q1 2020

May 15, 2020
SELL
$63.36 - $87.82 $38.6 Million - $53.5 Million
-608,696 Reduced 9.83%
5,582,103 $429 Million
Q4 2019

Feb 18, 2020
BUY
$77.58 - $87.54 $86,191 - $97,256
1,111 Added 0.02%
6,190,799 $563 Million
Q3 2019

Nov 14, 2019
SELL
$76.08 - $82.93 $76.2 Million - $83.1 Million
-1,001,801 Reduced 13.93%
6,189,688 $521 Million
Q2 2019

Aug 14, 2019
BUY
$69.84 - $81.59 $262,179 - $306,288
3,754 Added 0.05%
7,191,489 $603 Million
Q1 2019

May 15, 2019
SELL
$69.58 - $79.36 $313 Million - $357 Million
-4,501,887 Reduced 38.51%
7,187,735 $598 Million
Q4 2018

Feb 14, 2019
BUY
$65.24 - $75.71 $126,761 - $147,104
1,943 Added 0.02%
11,689,622 $893 Million
Q3 2018

Nov 14, 2018
BUY
$57.69 - $67.84 $260 Million - $305 Million
4,500,360 Added 62.62%
11,687,679 $829 Million
Q2 2018

Aug 14, 2018
BUY
$50.83 - $59.72 $155,590 - $182,802
3,061 Added 0.04%
7,187,319 $436 Million
Q1 2018

May 15, 2018
BUY
$50.96 - $59.23 $854,854 - $993,583
16,775 Added 0.23%
7,184,258 $391 Million
Q4 2017

Feb 14, 2018
SELL
$51.62 - $61.64 $73,764 - $88,083
-1,429 Reduced 0.02%
7,167,483 $403 Million
Q3 2017

Nov 14, 2017
BUY
$58.67 - $63.13 $421 Million - $453 Million
7,168,912
7,168,912 $459 Million

Others Institutions Holding MRK

# of Institutions
3,830
Shares Held
1.91B
Call Options Held
13.4M
Put Options Held
10.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email